Cytokines in Adipose-derived Mesenchymal Stem Cells Promote the Healing of Liver Disease

Overview

Journal World J Stem Cells

Publisher Baishideng Publishing Group

Date 2019 Jan 12

PMID 30631390

Citations 18

Authors

Saifun Nahar

Yoshiki Nakashima

Chika Miyagi-Shiohira

Takao Kinjo

Zensei Toyoda

Naoya Kobayashi

Issei Saitoh

Masami Watanabe

Hirofumi Noguchi

Jiro Fujita

Affiliations

Soon will be listed here.

Abstract

Adipose-derived mesenchymal stem cells (ADSCs) are a treatment cell source for patients with chronic liver injury. ADSCs are characterized by being harvested from the patient's own subcutaneous adipose tissue, a high cell yield (., reduced immune rejection response), accumulation at a disease nidus, suppression of excessive immune response, production of various growth factors and cytokines, angiogenic effects, anti-apoptotic effects, and control of immune cells via cell-cell interaction. We previously showed that conditioned medium of ADSCs promoted hepatocyte proliferation and improved the liver function in a mouse model of acute liver failure. Furthermore, as found by many other groups, the administration of ADSCs improved liver tissue fibrosis in a mouse model of liver cirrhosis. A comprehensive protein expression analysis by liquid chromatography with tandem mass spectrometry showed that the various cytokines and chemokines produced by ADSCs promote the healing of liver disease. In this review, we examine the ability of expressed protein components of ADSCs to promote healing in cell therapy for liver disease. Previous studies demonstrated that ADSCs are a treatment cell source for patients with chronic liver injury. This review describes the various cytokines and chemokines produced by ADSCs that promote the healing of liver disease.

Citing Articles

Role of Hedgehog Signaling Pathways in Multipotent Mesenchymal Stem Cells Differentiation.

Wu M, Mi J, Qu G, Zhang S, Jian Y, Gao C Cell Transplant. 2024; 33:9636897241244943.

PMID: 38695366 PMC: 11067683. DOI: 10.1177/09636897241244943.

Unlocking the versatile potential: Adipose-derived mesenchymal stem cells in ocular surface reconstruction and oculoplastics.

Surico P, Scarabosio A, Miotti G, Grando M, Salati C, Parodi P World J Stem Cells. 2024; 16(2):89-101.

PMID: 38455097 PMC: 10915950. DOI: 10.4252/wjsc.v16.i2.89.

Progress in Research on Stem Cells in Neonatal Refractory Diseases.

Huang F, He Y, Zhang M, Luo K, Li J, Li J J Pers Med. 2023; 13(8).

PMID: 37623531 PMC: 10455340. DOI: 10.3390/jpm13081281.

TNF-α/IL-1β-licensed hADSCs alleviate cholestatic liver injury and fibrosis in mice via COX-2/PGE2 pathway.

Luan X, Chen P, Li Y, Yuan X, Miao L, Zhang P Stem Cell Res Ther. 2023; 14(1):100.

PMID: 37095581 PMC: 10127380. DOI: 10.1186/s13287-023-03342-3.

Pain Alleviating Effect of Adipose-Derived Stem Cells Transplantation on the Injured Spinal Cord: A Behavioral and Electrophysiological Evaluation.

Yousefifard M, Sarveazad A, Janzadeh A, Behroozi Z, Nasirinezhad F J Stem Cells Regen Med. 2023; 18(2):53-63.

PMID: 36713791 PMC: 9837693. DOI: 10.46582/jsrm.1802010.

References

Ullah I, Subbarao R, Rho G . Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015; 35(2). PMC: 4413017. DOI: 10.1042/BSR20150025. View

Hamada E, Ebi N, Miyagi-Shiohira C, Tamaki Y, Nakashima Y, Kobayashi N . Comparison Between Modified Extracellular-Type Trehalose-Containing Kyoto Solution and University of Wisconsin Solution in 18-Hour Pancreas Preservation for Islet Transplantation. Pancreas. 2018; 47(7):e46-e47. DOI: 10.1097/MPA.0000000000001104. View

Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo J, Navarro-Alvarez N, Zhao D, Zhao D . Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol. 2006; 24(11):1412-9. DOI: 10.1038/nbt1257. View

Hibiya K, Utsunomiya K, Yoshida T, Toma S, Higa F, Tateyama M . Pathogenesis of systemic Mycobacterium avium infection in pigs through histological analysis of hepatic lesions. Can J Vet Res. 2011; 74(4):252-7. PMC: 2949337. View

Kluwe J, Pradere J, Gwak G, Mencin A, De Minicis S, Osterreicher C . Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology. 2009; 138(1):347-59. PMC: 2988578. DOI: 10.1053/j.gastro.2009.09.015. View

Fernandez M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J . Angiogenesis in liver disease. J Hepatol. 2009; 50(3):604-20. DOI: 10.1016/j.jhep.2008.12.011. View

Li Y, Turpin C, Wang S . Role of thrombospondin 1 in liver diseases. Hepatol Res. 2016; 47(2):186-193. PMC: 5292098. DOI: 10.1111/hepr.12787. View

Hautekeete M, Geerts A . The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch. 1997; 430(3):195-207. DOI: 10.1007/BF01324802. View

Kotoh K, Nakamuta M, Kohjima M, Fukushima M, Morizono S, Kobayashi N . Arg-Gly-Asp (RGD) peptide ameliorates carbon tetrachloride-induced liver fibrosis via inhibition of collagen production and acceleration of collagenase activity. Int J Mol Med. 2004; 14(6):1049-53. View

10.

Tacke F, Zimmermann H, Trautwein C, Schnabl B . CXCL5 plasma levels decrease in patients with chronic liver disease. J Gastroenterol Hepatol. 2011; 26(3):523-9. PMC: 3058722. DOI: 10.1111/j.1440-1746.2010.06436.x. View

11.

Shang H, Liu X, Guo H . Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway. Mol Med Rep. 2017; 16(5):7119-7123. DOI: 10.3892/mmr.2017.7445. View

12.

Elpek G . Angiogenesis and liver fibrosis. World J Hepatol. 2015; 7(3):377-91. PMC: 4381164. DOI: 10.4254/wjh.v7.i3.377. View

13.

Huntley R, Sawford T, Martin M, ODonovan C . Understanding how and why the Gene Ontology and its annotations evolve: the GO within UniProt. Gigascience. 2014; 3(1):4. PMC: 3995153. DOI: 10.1186/2047-217X-3-4. View

14.

Zimmers T, McKillop I, Pierce R, Yoo J, Koniaris L . Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology. 2003; 38(2):326-34. DOI: 10.1053/jhep.2003.50318. View

15.

Nakashima Y, Nahar S, Miyagi-Shiohira C, Kinjo T, Kobayashi N, Saitoh I . A Liquid Chromatography with Tandem Mass Spectrometry-Based Proteomic Analysis of Cells Cultured in DMEM 10% FBS and Chemically Defined Medium Using Human Adipose-Derived Mesenchymal Stem Cells. Int J Mol Sci. 2018; 19(7). PMC: 6073410. DOI: 10.3390/ijms19072042. View

16.

Kobayashi N, Okitsu T, Tanaka N . Cell choice for bioartificial livers. Keio J Med. 2003; 52(3):151-7. DOI: 10.2302/kjm.52.151. View

17.

Arata T, Okitsu T, Fukazawa T, Ikeda H, Kobayashi K, Yong C . Maintenance of glucose-sensitive insulin secretion of cryopreserved human islets with University of Wisconsin solution and ascorbic acid-2 glucoside. Artif Organs. 2004; 28(6):529-36. DOI: 10.1111/j.1525-1594.2004.07296.x. View

18.

Kobayashi N, Noguchi H, Westerman K, Watanabe T, Matsumura T, Totsugawa T . Successful retroviral gene transfer of simian virus 40 T antigen and herpes simplex virus-thymidine kinase into human hepatocytes. Cell Transplant. 2001; 10(4-5):377-81. View

19.

Liu X, Liu R, Hou F, Cui L, Li C, Chi C . Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro. Mol Med Rep. 2016; 14(4):3669-75. PMC: 5042748. DOI: 10.3892/mmr.2016.5673. View

20.

Watanabe T, Shibata N, Westerman K, Okitsu T, Allain J, Sakaguchi M . Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation. 2003; 75(11):1873-80. DOI: 10.1097/01.TP.0000064621.50907.A6. View